Where therapy meets prevention

This round table discussion, held by the New Statesman with Pfizer, examines where we can expect the leaps in development of medicine over the next few decades. Personalised approaches to therapy and prevention will come out of a revolution in healthcare, driven by advances in knowledge and communication.

[Download as PDF]

[Read as HTML]



Participants

Dr Richard Barker
Director general, Association of the British Pharmaceutical Industry

Professor John Bell
Regius professor of medicine, Oxford University; chair, UK Biobank Science Committee

Dr Simon Best
Chairman, Ardana Plc; Chairman, Bioindustry Association

Professor Dame Carol Black
President, Royal College of Physicians of London

Professor Colin Blakemore
Chief exec, Medical Research Council; Waynflete professor of physiology, Oxford University

Professor Sally Davies
Director of research And development, Department of Health

Dr Annette Doherty
Senior Vice-President Pfizer Global Research And Development

Dr Ian Gibson MP
Member of parliament for Norwich North; chair, All Party Parliamentary Group on Cancer

Geoff Lee
Director of global strategic policy, GE Healthcare

Professor Peter Littlejohns
Clinical and public health director, National Institute For Health and Clinical Excellence (NICE)

Professor Salvador Moncada
Director, The Wolfson Institute for Biomedical Research, University College London

Sarah Montague (Chair)
Presenter, BBC Radio 4 Today Programme

Professor Robin Murray
Professor of psychiatry, Institute of Psychiatry, Kings College London

Professor Shervanthi Homer-Vanniasinkam
Chair of the Institute of Nanotechnology's NanoMedNet; professor of clinical and experimental vascular research, University of Bradford

Professor Anthony Segal
Director, Centre For Molecular Medicine, University College London

Professor Ijeoma Uchegbu
Professor of drug delivery, University of Strathclyde; chairperson of the Academy of Pharmaceutical Sciences of Great Britain

Professor Sir Magdi Yacoub Frs
Cardiothoracic surgeon, department of technology and oncology, Imperial College London

[Download as PDF]

[Read as HTML]